The expression of MAOA has been discovered to be high in prostate cancer and its overexpression in prostate oncocyte perineural aggression via SEMA3C/PlexinA2/NRP1-cMET signal transmission [27]. This evidence concerns the gene SEMA3C and prostate carcinoma.